Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 278, Issue 6 41-6, 2000, Pages

  Rennick, Donna M ^a   Fort, Madeline M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Counterregulation by IL 10; IL 10 therapy; Interleukin; Proinflammatory cytokines; Th1 mediated intestinal disease

Indexed keywords

CYTOKINE; INTERLEUKIN 10;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; COLITIS; CYTOKINE PRODUCTION; ENTERITIS; ENTEROCOLITIS; GENETIC ENGINEERING; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TH1 CELL;

EID: 0033948508     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2000.278.6.g829     Document Type: Review

References (31)

1. Asseman C, Mauze S, Leach MW, Coffman RL, and Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190: 995-1003, 1999.
2. + TH1-like responses. J Clin Invest 98: 1010-1020, 1996.
3. Berg DJ, Lauricella D, Lynch R, Lynch N, and Rennick D. Locally-advanced and metastatic colon cancer in p53-deficient IL-10-/- mice (Abstract). Exper Biol 99 Annu Meeting, Washington DC, 1999.
4. Blumberg RS, Saubermann LJ, and Strober W. Animal models of mucosa inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 11: 648-656, 1999.
5. Boirivant M, Fuss IJ, Chu A, and Strober W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 188: 1929-1939, 1998.
6. Davidson NJ, Fort MM, Müller W, Leach MW, and Rennick DM. Insufficient counter regulation of a Th1 response. Int Rev Immunol 19: 91-121, 2000.
7. Davidson NJ, Hudak SA, Lesley RE, Menon S, Leach MW, and Rennick DM. IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol 161: 3143-3149, 1998.
8. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184: 241-251, 1996.
9. Deventer SJ van, Elson CO, and Fedorak RN. Multiple doses of intravenous interleukin-10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group. Gastroenterology 113: 383-389, 1997.
10. Duchmann R, Schmitt E, Knolle P, Meyer zum Büschenfelde, KH, and Neurath M. Tolerance towards residential flora in mice is abrogated in experimental colitis and restored by treatment with interleukin 10 or antibodies to interleukin 12. Eur J Immunol 26: 934-938, 1996.
11. Ehrhardt RO, Lídvíksson BR, Gray B, Neurath M, and Strober W. Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol 158: 566-573, 1997.
12. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742, 1997.
13. Herfarth HH, Mohnaty SP, Rath HC, Tonkonogy S, and Sartor RB. Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 39: 836-845, 1996.
14. Hermiston ML and Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 270: 1203-1207, 1995.
15. Kojouharoff G, Hans W, Obermeier F, Männel DN, Andus T, Schölmerich J, Gross V, and Falk W. Neutralization of tumor necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sodium sulfate-induced colitis in mice. Clin Exp Immunol 107: 353-358, 1997.
16. Kühn R, Löhler J, Rennick D, Rajewsky K, and Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274, 1993.
17. Kullberg MC, Ward MJ, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankove D, and Sher A. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin (IL-10)-deficient mice through an IL-12- and gamma-interferon-dependent mechanism. Infect Immun 66: 5157-5166, 1998.
18. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, and Fedorak RN. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116: 1107-1114, 1999.
19. Mizoguchi A, Mizoguchi E, and Bhan AK. The critical role of interleukin 4 but not interferon gamma in the pathogenesis of colitis in T-cell receptor α mutant mice. Gastroenterology 116: 320-326, 1999.
20. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, and Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75: 275-282, 1993.
21. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, and Mosmann TR. Interleukin-10. Annu Rev Immunol 11: 165-190, 1993.
22. Neurath MF, Fuss I, Kelsall BL, Stüber E, and Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182: 1281-1290, 1995.
23. Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Büschenfelde KH, Strober W, and Kollias G. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 27: 1743-1750, 1997.
24. Neurath MF, Pettersson S, Meyer-zum Büschenfelde KH, and Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NFkappa B abrogates established experimental colitis in mice. Nat Med 2: 998-1004, 1996.
25. + T cells. Immunity 1: 553-562, 1994.
26. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Braget P, Boulya G, Bradley A, and Birnbaumer L. Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice. Nat Genet 10: 693-699, 1995.
27. Schreiber SHT, Thiele HG, and Raedler A. Experimental immunomodulatory therapy of inflammatory bowel disease. Neth J Med 53: S24-S31, 1998.
28. Sellon RK, Tonkonogy S, Schultz M, Duieleman LA, Grenther W, Balish E, Rennick DM, and Sartor RB. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5222-5231, 1998.
29. Simpson SJ, Shah S, Comiskey M, de Jong YP, Wang B, Mizoguchi E, Bhan AK, and Terhorst C. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin12/signal transducer and activator of transcription (stat)-4 pathway, but is not conditional on interferon-γ expression by T cells. J Exp Med 1998: 1225-1234, 1998.
30. Spencer SD, DiMarco F, Hooley J, Pitts-Meek S, Bauer M, Ryan AM, Sordat B, Gibbs VC, and Aguet M. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med 187: 571-578, 1998.
31. Watanabe M, Ueno Y, Yajime T, Iwao Y, Tsuchiya M, Ishikawa H, Aiso S, Hibi T, and Ishii H. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J Clin Invest 95: 2945-2953, 1995.